NCT00591890View on ClinicalTrials.gov

Phase IB Study of Indibulin Using Positron-Emission Tomography (PET) Scans

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

June 30, 2008

Study Completion Date

March 31, 2009

Conditions
Advanced Cancer
Interventions
DRUG

indibulin

dose escalation of indibulin given twice daily for 21 days, to be repeated every 28 days.

Trial Locations (1)

Unknown

Santa Monica

Sponsors
All Listed Sponsors
lead

Alaunos Therapeutics

INDUSTRY